Biote Announces Participation in the Jefferies Healthcare Conference 2022

IRVING, Texas--(BUSINESS WIRE)-- biote Corp. (“Biote” or the “Company”) (Nasdaq: BTMD), a high growth, differentiated medical practice-building business within the hormone optimization space, today announces that Terry Weber, Biote’s Chief Executive Officer, is scheduled to present at the Jefferies 2022 Healthcare Conference in New York City on Wednesday, June 8, 2022 at 1:30 p.m. Eastern Time. A live webcast of the presentation will be available here. A replay of the available webcast will be accessible for 90 days following the live event.

Terry Weber and Marc Beer, Biote’s Chairman, will also be participating in investor meetings throughout the conference.

About Biote

Biote is a woman-led company operating a high growth, differentiated medical practice-building business within the hormone optimization space. Biote trains practitioners how to identify and treat early indicators of hormone-related aging conditions. Biote went public on Nasdaq on May 27, 2022. To learn more about Biote, please visit www.biote.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20220606005929/en/

Media
Karen Chase
[email protected]

Investors
Mike Cavanaugh
[email protected]

Source: Biote Corp.

You May Also Be Interested In

• Fujirebio Expands Access in Canada to Blood-based Neurology Testing with Health Canada Class II Medical Device Licenses for the Lumipulse® G NfL Blood and Lumipulse G pTau 217 Plasma Assays
• Manta’s Under the Oak Tree Lands on USA TODAY Bestseller List
• argenx to Present at Upcoming Investor Conferences